TY  - GEN 
AU  - Blancas, I.
AU  - Olier, C.
AU  - Conde, V.
AU  - Bayo, J.L.
AU  - Herrero, C.
AU  - Zarcos‑Pedrinaci, I.
AU  - Carabantes, F.
AU  - Baena Cañada, José Manuel
AU  - Cruz, J.
AU  - Ruiz‑Borrego, M.
A4  - Medicina
PY  - 2021
SN  - 2045-2322
UR  - http://hdl.handle.net/10498/24691
AB  - Goals of endocrine therapy for advanced breast cancer (ABC) include prolonging survival rates, maintaining the quality of life, and delaying the initiation of chemotherapy. We evaluated the effectiveness of fulvestrant as first-line in patients with...
LA  - eng
PB  - NATURE RESEARCH
TI  - Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer
DO  - 10.1038/s41598-021-83622-1
ER  -